Skip to main content
Signal8

Hall Kimball

SEC insider (Form 3/4/5 filer). CIK 0001897965. Director at Vera Therapeutics, Inc. (VERA). 2 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in BRISBANE, CA.

Companies Hall Kimball has filed insider reports for

  • Vera Therapeutics, Inc. (VERA): Director
Hall Kimball profile photo

Hall Kimball

CIK: 0001897965

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Vera Therapeutics, Inc. logo
VERA

Vera Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Vera Therapeutics, Inc. logo
    VERA

    Vera Therapeutics, Inc.

    May 21, 2026
    Award

    Stock Option (right to buy)

    Direct
    17.1K shares-
  • Vera Therapeutics, Inc. logo
    VERA

    Vera Therapeutics, Inc.

    May 14, 2025
    Award

    Stock Option (right to buy)

    Direct
    14K shares-

1-2 of 2